[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[Janux Therapeutics, Inc. Common Stock](/topic/$janx)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$janx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$janx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +35%  
**6 Months**: XX% -X%  
**1 Year**: XX% +40%  
**1-Year High**: XXX% on 2025-03-30  
**1-Year Low**: XX% on 2024-11-21  

**Most Supportive Themes**
- **Analyst Price Targets and Positive Ratings:** (30%) Leerink reiterates an outperform rating and a $XX price target for JANX.
- **Tumor-Conditional Masking Platform:** (25%) The company's innovative tumor-conditional masking platform is generating interest.
- **Biotech Sector Attractiveness:** (20%) JANX is seen as an attractive target for pharmaceutical companies.
  
**Most Critical Themes**
- **Market Volatility:** (15%)  The stock has experienced price fluctuations, with a XXXX% decrease in the last XX hours.
- **Low Engagement Compared to Daily Average:** (10%)  Engagements are down significantly compared to the daily average.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXX      | XX% | XXX     | XX% | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXX      | XX% | XXX     | XX% | XX       | X% |